Family Medicine Doctors in Painesville, OH Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Dr. Paul Canning Hanahan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 50 Normandy Dr Ste 5, Painesville, OH 44077 Phone: 440-354-4747    Fax: 440-354-3530

Dr. Gary Allen Posner, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7536 Fredle Dr, Painesville, OH 44077 Phone: 216-524-7377    Fax: 440-350-6520

Glenn Beck, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 470 Bacon Rd, Painesville, OH 44077 Phone: 440-354-9900    Fax: 440-354-9910

Charita Ray, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 470 Bacon Rd, Painesville, OH 44077 Phone: 440-743-3006

Dr. Lynn Alderson Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Mentor Ave Ste 2, Painesville, OH 44077 Phone: 440-354-4312    Fax: 440-357-7734

News Archive

A DNA-based vaccine shows promise against avian flu

Though it has fallen from the headlines, a global pandemic caused by bird flu still has the United States' Centers for Disease Control and Prevention on high alert. Yet, to date, the only vaccines that have proven even semi-effective are produced in chicken eggs, take five to six months to prepare and act against a single variant of the H5N1 virus, which mutates incredibly quickly.

Only 50% of lung cancer patients in England are getting lifesaving surgery

Only half as many lung cancer patients in England are getting potentially lifesaving surgery compared to the best countries in the world, according to a new report by the National Cancer Intelligence Network (NCIN).

A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection

The cover for issue 10 of Oncotarget features Figure 3, "Overall survival (OS) for high (red) versus low (black) risk groups in the (A) OSU, (B) TCGA, and (C) SNU resected cohorts," by Wolfe, et al.

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the U.S. FDA has agreed with the Company's study protocol for its Phase II clinical trial of CF102 for the treatment of advanced liver cancer.

Read more Medical News

› Verified 1 days ago